[{"from": "human", "value": "Provide a brief overview of this molecule. [C][C][=Branch1][C][=O][N][C][C][Branch2][#Branch2][C][C][Branch2][Ring1][Ring1][C][Branch1][=Branch1][O][C][Ring1][=Branch1][O][C][O][S][=Branch1][C][=O][=Branch1][C][=O][O][O][C][C][Branch2][#Branch1][=N][C][Branch2][#Branch1][Branch2][C][Branch1][N][C][Branch1][Ring2][O][Ring1][=Branch1][C][=Branch1][C][=O][O][O][C][C][Branch2][Branch1][O][C][Branch2][Ring2][=C][C][Branch1][=Branch2][C][Branch1][Ring2][O][Ring1][=Branch1][C][O][O][C][C][Branch2][Ring1][Ring2][C][Branch1][S][C][Branch1][N][C][Branch1][Ring2][O][Ring1][=Branch1][C][=Branch1][C][=O][O][O][O][O][S][=Branch1][C][=O][=Branch1][C][=O][O][O][S][=Branch1][C][=O][=Branch1][C][=O][O][N][S][=Branch1][C][=O][=Branch1][C][=O][O][O][O][S][=Branch1][C][=O][=Branch1][C][=O][O][O]"}, {"from": "gpt", "value": "The molecule is a low molecular weight, synthetic heparin. As an anticoagulant/antithrombotic agent, enoxaprin's mechanism of action is similar to that of heparin, although it exhibits a higher ratio of anti-Factor Xa to anti-Factor IIa activity. This agent also has anti-inflammatory properties, inhibiting monocyte adhesion to tumor necrosis factor alpha- or lipopolysaccharide-activated endothelial cells.  Compared to unfractionated heparins, the use of enoxaparin is associated with lower incidences of osteoporosis and heparin-induced thrombocytopenia. (NCI04)"}]